Robert H. Gerner

4.0k total citations
66 papers, 3.0k citations indexed

About

Robert H. Gerner is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert H. Gerner has authored 66 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 17 papers in Pharmacology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert H. Gerner's work include Treatment of Major Depression (16 papers), Tryptophan and brain disorders (10 papers) and Bipolar Disorder and Treatment (9 papers). Robert H. Gerner is often cited by papers focused on Treatment of Major Depression (16 papers), Tryptophan and brain disorders (10 papers) and Bipolar Disorder and Treatment (9 papers). Robert H. Gerner collaborates with scholars based in United States and United Kingdom. Robert H. Gerner's co-authors include T.A. Hare, Tadataka Yamada, James E. Spar, Robert M. Post, Harry E. Gwirtsman, H E Gwirtsman, Deborah J. Gerner, Bonnie B. Dean, William E. Bunney and Michael Gitlin and has published in prestigious journals such as JAMA, American Journal of Psychiatry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Robert H. Gerner

62 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert H. Gerner 1.1k 800 660 509 479 66 3.0k
L. Trevor Young 1.6k 1.5× 1.1k 1.4× 649 1.0× 513 1.0× 555 1.2× 45 3.7k
Robert M. Post 2.1k 1.9× 919 1.1× 662 1.0× 333 0.7× 316 0.7× 60 3.8k
Philip A. Berger 863 0.8× 956 1.2× 273 0.4× 452 0.9× 371 0.8× 93 3.0k
Leif Lindström 1.3k 1.2× 862 1.1× 526 0.8× 236 0.5× 805 1.7× 63 3.1k
D. Eccleston 949 0.9× 1.4k 1.8× 296 0.4× 573 1.1× 575 1.2× 94 3.5k
David Bakish 932 0.9× 1.1k 1.4× 643 1.0× 920 1.8× 472 1.0× 73 3.1k
Ralph A. O’Connell 1.2k 1.1× 1.3k 1.6× 584 0.9× 418 0.8× 205 0.4× 32 3.4k
Marco Catalano 928 0.9× 1.3k 1.7× 594 0.9× 387 0.8× 327 0.7× 49 2.8k
Malcolm B. Bowers 1.9k 1.8× 1.6k 2.0× 675 1.0× 712 1.4× 558 1.2× 136 4.2k
Jean‐Michel Aubry 1.1k 1.0× 1.3k 1.7× 852 1.3× 484 1.0× 633 1.3× 72 4.1k

Countries citing papers authored by Robert H. Gerner

Since Specialization
Citations

This map shows the geographic impact of Robert H. Gerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Gerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Gerner more than expected).

Fields of papers citing papers by Robert H. Gerner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Gerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Gerner. The network helps show where Robert H. Gerner may publish in the future.

Co-authorship network of co-authors of Robert H. Gerner

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Gerner. A scholar is included among the top collaborators of Robert H. Gerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Gerner. Robert H. Gerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dean, Bonnie B., Deborah J. Gerner, & Robert H. Gerner. (2004). A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Current Medical Research and Opinion. 20(2). 139–154. 217 indexed citations
2.
Kaufman, Kenneth R. & Robert H. Gerner. (2003). Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: case analysis and literature review. Epilepsy & Behavior. 4(6). 766–770. 3 indexed citations
3.
Kaufman, Kenneth R. & Robert H. Gerner. (1998). Lamotrigine toxicity secondary to sertraline. Seizure. 7(2). 163–165. 71 indexed citations
4.
Gerner, Robert H., et al.. (1992). Algorithm for Patient Management of Acute Manic States. Journal of Clinical Psychopharmacology. 12(Supplement). 57S–63S. 27 indexed citations
5.
DeMet, Edward M., et al.. (1991). Decreased seasonal mesor of platelet 3H-imipramine binding in depression. Biological Psychiatry. 29(5). 427–440. 13 indexed citations
6.
DeMet, Edward M., et al.. (1990). Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisol. Psychiatry Research. 34(3). 303–313. 1 indexed citations
7.
DeMet, Edward M., et al.. (1990). Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depression. Psychiatry Research. 34(3). 315–329. 2 indexed citations
8.
DeMet, Edward M., et al.. (1989). Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent. Biological Psychiatry. 26(5). 478–488. 15 indexed citations
9.
Gerner, Robert H.. (1987). Geriatric Depression and Treatment with Trazodone. Psychopathology. 20(1). 82–91. 10 indexed citations
10.
Sandman, Curt A., et al.. (1987). Event-related potentials and item recognition in depressed, schizophrenic and alcoholic patients. International Journal of Psychophysiology. 5(3). 215–225. 23 indexed citations
11.
Gerner, Robert H., et al.. (1985). Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 9(1). 73–82. 37 indexed citations
12.
Neshkes, Robert E., Robert H. Gerner, Lissy F. Jarvik, et al.. (1985). Orthostatic Effect of Imipramine and Doxepin in Depressed Geriatric Outpatients. Journal of Clinical Psychopharmacology. 5(2). 102–108. 25 indexed citations
13.
Gwirtsman, Harry E., Peter Roy‐Byrne, Joel Yager, & Robert H. Gerner. (1983). Neuroendocrine abnormalities in bulimia. American Journal of Psychiatry. 140(5). 559–563. 204 indexed citations
14.
Wolf, Stewart, Michael E. Felver, Mark D. Altschule, et al.. (1983). Abnormal Metabolite in Alcoholic Subjects. The British Journal of Psychiatry. 142(4). 388–390. 9 indexed citations
15.
Gwirtsman, Harry E., Robert H. Gerner, & Harvey Sternbach. (1982). The overnight dexamethasone suppression test: clinical and theoretical review.. PubMed. 43(8). 321–7. 17 indexed citations
16.
Gerner, Robert H.. (1981). Dr. Gerner Replies. American Journal of Psychiatry. 138(9). 1259–1259. 77 indexed citations
17.
Hare, Theodore A., James H. Wood, N.V.Bala Manyam, et al.. (1980). Selection of control populations for clinical cerebrospinal fluid GABA investigations based on comparison with normal volunteers. Brain Research Bulletin. 5. 721–724. 20 indexed citations
18.
Gerner, Robert H., et al.. (1980). A placebo-controlled double-blind study of imipramine and trazodone in geriatric depression.. PubMed. 69. 167–82. 14 indexed citations
19.
Gerner, Robert H., et al.. (1980). Results of clinical renal function tests in lithium patients. American Journal of Psychiatry. 137(7). 834–837. 19 indexed citations
20.
Gerner, Robert H., Robert M. Post, Christian Gillin, & William E. Bunney. (1979). Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals. Journal of Psychiatric Research. 15(1). 21–40. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026